KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Income from Non-Controlling Interests (2021 - 2025)

Thermo Fisher Scientific (TMO) has disclosed Income from Non-Controlling Interests for 4 consecutive years, with -$6.0 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Income from Non-Controlling Interests rose 75.0% year-over-year to -$6.0 million, compared with a TTM value of -$23.0 million through Dec 2024, down 15.0%, and an annual FY2025 reading of $17.0 million, up 466.67% over the prior year.
  • Income from Non-Controlling Interests was -$6.0 million for Q4 2024 at Thermo Fisher Scientific, down from $4.0 million in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $5.0 million in Q2 2022 and bottomed at -$24.0 million in Q4 2023.
  • Average Income from Non-Controlling Interests over 4 years is -$909090.9, with a median of $1.0 million recorded in 2021.
  • The sharpest move saw Income from Non-Controlling Interests surged 300.0% in 2022, then crashed 1100.0% in 2023.
  • Year by year, Income from Non-Controlling Interests stood at $1.0 million in 2021, then plummeted by 300.0% to -$2.0 million in 2022, then plummeted by 1100.0% to -$24.0 million in 2023, then soared by 75.0% to -$6.0 million in 2024.
  • Business Quant data shows Income from Non-Controlling Interests for TMO at -$6.0 million in Q4 2024, $4.0 million in Q1 2024, and -$24.0 million in Q4 2023.